Home › Malattie polmonari interstiziali › Pennsylvania
Studi clinici su Malattie polmonari interstiziali nello stato di Pennsylvania
18 studi su Malattie polmonari interstiziali cercano partecipanti presso sedi nello stato di Pennsylvania.
Città nello stato di Pennsylvania
Testo ufficiale dello studio (inglese)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Pennsylvania, Philadelphia
- Temple University, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of Pennsylvania, Philadelphia
In reclutamentoFase 3
Età 40 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA013, Philadelphia
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Thomas Jefferson University, Philadelphia
- Temple Lung Center, Temple University, Philadelphia
- UPMC Montefiore, Pittsburgh
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT05798923A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Philadelphia
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06572384A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Pittsburgh
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT05878717Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Thomas Jefferson University, Philadelphia
- Temple University of The Commonwealth System of Higher Education, Philadelphia
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06911632Dorothy P. and Richard P. Simmons Center for ILD Research Registry
- Michelle F MacPherson, Pittsburgh
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT00258583DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- St. Luke's University Health Network, Bethlehem
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University - Sidney Kimmel Medical College, Philadelphia
- e altri 2
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 26 ago 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 ago 2026 · NCT06195072Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
In reclutamentoFase 2
Età da 8 a 60 · Tutti i sessi · Aggiornato il 14 ago 2026 · NCT03630211Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Temple University, Philadelphia
- Thomas Jefferson University, Philadelphia
In reclutamentoStudio osservazionale
Età 21 e oltre · Tutti i sessi · Aggiornato il 12 ago 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Temple University, Philadelphia
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 10 ago 2026 · NCT07175038Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Pennsylvania State Hershey Medical Center and College of Medicine, Hershey
- Hospital of the University of Pennsylvania, Philadelphia
- Jefferson Honickman Center, Philadelphia
- e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 lug 2026 · NCT05943535TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Children's Hospital of Philadelphia, Philadelphia
In reclutamentoStudio osservazionale
Fino a 24 anni · Tutti i sessi · Aggiornato il 22 giu 2026 · NCT04098445Feasibility of Semaglutide in Advanced Lung Disease
- University of Pennsylvania Perelman School of Medicine, Philadelphia
In reclutamentoFase 1/2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 21 apr 2026 · NCT05746039Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Temple University Hospital-Temple Lung Center, Philadelphia
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 12 nov 2025 · NCT05975983Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.